by The global Active Pharmaceutical Ingredient market size is expected to surpass around US$ 285.5 billion by 2027 and the market is expected to garner growth at a CAGR of 6.82% over the forecast period 2021 to 2027.
The Active Pharmaceutical Ingredient market report covers a detailed analysis for the historic period 2017-2020, considering 2021 as the base year and forecast (growth) for 2021-2027.
Get the sample copy of this report@ https://www.precedenceresearch.com/sample/1035
Growth Factors
Continuously growing prevalence of chronic illness, escalating significance of generics, and the cumulative uptake of biopharmaceuticals are some of the prime factors stimulating the growth of the active pharmaceutical ingredient market globally. Alternatively, the critical drug price control policies in numerous nations and the swelling diffusion of counterfeit drugs may hamper the growth of API market in these nations during next few years. As per, 2017 NCBI article on a survey directed in a tertiary hospital in Japan, about 339 bacteremia UTI cases were identified. Thus, escalating occurrence of such infectious sickness and hospital-acquired contaminations are projected to stimulate growth of API market in the nearby future.
Some of the prime factors spurring the growth of the market are increasing occurrences of cardiovascular, oncology, lifestyle and diabetes diseases, intensifying number of diagnostic centers and hospitals and escalating elderly population in emerging countries. Furthermore, cumulative healthcare spending, growing disease responsiveness and education are propelling the growth of the market. Conversely, a shortage of accomplished workforce and inadequate accessibility of drugs in the emerging nations are hampering the growth of the market in these regions.
Market Report Scope
| Report Highlights | Details |
| Market Size | USD 285.5 Billion by 2027 |
| Growth Rate | CAGR of 6.82% from 2021 to 2027 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2027 |
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1035
Market Overview
A recent study by Precedence Research on the Active Pharmaceutical Ingredient market offers a forecast for 2021 and 2027. The study analyzes crucial trends that are currently determining the growth of the Active Pharmaceutical Ingredient market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of Active Pharmaceutical Ingredient. The study also provides the dynamics that are responsible for influencing the future status of the Active Pharmaceutical Ingredient market over the forecast period.
A detailed assessment of the Active Pharmaceutical Ingredient market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the Active Pharmaceutical Ingredient market along with their product portfolio enhances the reliability of this comprehensive research study.
Report Highlights
- Some of the tactical initiatives commenced by many business players to sustain stability in the market are biological products, new drugs launches, collaborations, acquisitions, and geographical expansion.
- Oncology is projected to be the fastest-growing segment driven by developing pervasiveness of cancer and cumulative lifestyle-associated sicknesses.
- In the event of outsourcing, APIs are subject to strict regulations and omission from the nation they are shipped to. For example, API manufacturing plants abroad still go via an scrutiny by the U.S. Food & Drug Administration.
- API market has observed marvelous growth since last few decades due to augmented application of biologics and drugs in the treatment of diseases.
Regional Snapshots
In 2019, North America conquered the global market on account of high economic development plus widespread technological innovations in the region. Snowballing pervasiveness of cancer and other lifestyle-related illnesses inspires R&D undertakings by crucial market participants, thus enhancing the growth of the market. Asia Pacific is anticipated to record fastest growth in the market throughout the estimate period. On account of obtainability of affordable labor, foremost corporations in the market are setting up API business plants in emerging nations such as India and China.
OBJECTIVES OF THE STUDY
- To analyze and forecast the electric motor market, in terms of value and volume
- To provide information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To define, segment, and project the size of the global electric motor market on the product type, end-use and other segments
- To project the size of the market, with respect to five main regions, namely, North America, Europe, Asia Pacific (APAC), the Middle East & Africa, and South America, with their key countries
- To strategically analyze micro markets with respect to individual growth trends, growth prospects, and their contribution to the total market
- To analyze opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
- To strategically profile key players and comprehensively analyze their core competencies
- To track and analyze research & development (R&D) and competitive developments such as joint ventures, mergers & acquisitions, and new product developments in the electric motor market
Research Methodology
- Market estimate for 2020
- Average selling price (ASP) per region for specific product type
- Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
- Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
- National government documents, statistical databases
- News articles, press releases, and webcasts specific to companies operating in the market
- Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
- Determination of market penetration by country
Major Players Covered in this Report
The updated market research report on electric motor market allows the buyers and manufacturers to stay updated with the current market trends, ongoing happenings, and a clear picture on the market scenario. List of key players included in the research report will help the market vendors to know their market position and plan more operational strategies to gain topmost position among other players. The report offers crucial company information on each market player, such as company profile, financial information, and recently adopted growth strategies. This will help other existing players and the new entrants to plan strategies and establish their presence in the market.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
- Company Overview
- Company Market Share/Positioning Analysis
- Product Offerings
- Financial Performance
- Recent Initiatives
- Key Strategies Adopted by Players
- Vendor Landscape
- List of Suppliers
- List of Buyers
Major key players operating in the market are
- Albemarle Corporation
- AurobindoPharma
- Reddy’s Laboratories Ltd.
- AbbVieInc
- Teva Pharmaceutical Industries Ltd
- Mylan N.V.
- CiplaInc
- BoehringerIngelheim International GmbH
- Merck & Co., Inc
- Sun Pharmaceutical Industries Ltd
- Bristol-Myers Squibb Company
Segments Covered in the Report
By Type of Manufacturer
- Merchant APIs
- Captive APIs
By Type
- Generic APIs
- Innovative APIs
By Type of Synthesis
- Biotech
- Recombinant Proteins
- Monoclonal Antibodies
- Vaccines
- Synthetic
By Application
- Orthopedic
- Pulmonology
- Gastroenterology
- Endocrinology
- Cardiology
- Oncology
- CNS & Neurology
- Nephrology
- Ophthalmology
- Others
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Middle East & Africa
- Latin America
Why should you invest in this report?
If you are aiming to enter the global Active Pharmaceutical Ingredient market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for Active Pharmaceutical Ingredient are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2027, so that you can plan your strategies to enter this market accordingly. Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Active Pharmaceutical Ingredient Market, By Type of Manufacturer
7.1. Active Pharmaceutical Ingredient Market, by Type of Manufacturer Type, 2020-2027
7.1.1. Merchant APIs
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Captive APIs
7.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Active Pharmaceutical Ingredient Market, By Type
8.1. Active Pharmaceutical Ingredient Market, by Type, 2020-2027
8.1.1. Generic APIs
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Innovative APIs
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Active Pharmaceutical Ingredient Market, By Type of Synthesis
9.1. Active Pharmaceutical Ingredient Market, by Type of Synthesis, 2020-2027
9.1.1. Biotech (Recombinant Proteins, Monoclonal Antibodies, Vaccines)
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Synthetic
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Active Pharmaceutical Ingredient Market, By Application
10.1. Active Pharmaceutical Ingredient Market, by Application, 2020-2027
10.1.1. Orthopedic
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Pulmonology
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Gastroenterology
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Endocrinology
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Cardiology
10.1.5.1. Market Revenue and Forecast (2016-2027)
10.1.6. Oncology
10.1.6.1. Market Revenue and Forecast (2016-2027)
10.1.7. CNS & Neurology
10.1.7.1. Market Revenue and Forecast (2016-2027)
10.1.8. Nephrology
10.1.8.1. Market Revenue and Forecast (2016-2027)
10.1.9. Other
10.1.9.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Active Pharmaceutical Ingredient Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.1.2. Market Revenue and Forecast, by Type (2016-2027)
11.1.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.1.4. Market Revenue and Forecast, by Application (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Type (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.1.5.4. Market Revenue and Forecast, by Application (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Type (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.1.6.4. Market Revenue and Forecast, by Application (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.2.2. Market Revenue and Forecast, by Type (2016-2027)
11.2.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.2.4. Market Revenue and Forecast, by Application (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Type (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.2.5.4. Market Revenue and Forecast, by Application (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Type (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.2.6.4. Market Revenue and Forecast, by Application (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Type (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.2.7.4. Market Revenue and Forecast, by Application (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Type (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.2.8.4. Market Revenue and Forecast, by Application (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.3.2. Market Revenue and Forecast, by Type (2016-2027)
11.3.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.3.4. Market Revenue and Forecast, by Application (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Type (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.3.5.4. Market Revenue and Forecast, by Application (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Type (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.3.6.4. Market Revenue and Forecast, by Application (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Type (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.3.7.4. Market Revenue and Forecast, by Application (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Type (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.3.8.4. Market Revenue and Forecast, by Application (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.4.2. Market Revenue and Forecast, by Type (2016-2027)
11.4.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.4.4. Market Revenue and Forecast, by Application (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Type (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.4.5.4. Market Revenue and Forecast, by Application (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Type (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.4.6.4. Market Revenue and Forecast, by Application (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Type (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.4.7.4. Market Revenue and Forecast, by Application (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Type (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.4.8.4. Market Revenue and Forecast, by Application (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.5.2. Market Revenue and Forecast, by Type (2016-2027)
11.5.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.5.4. Market Revenue and Forecast, by Application (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Type (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.5.5.4. Market Revenue and Forecast, by Application (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Type of Manufacturer (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Type (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Type of Synthesis (2016-2027)
11.5.6.4. Market Revenue and Forecast, by Application (2016-2027)
Chapter 12. Company Profiles
12.1. Albemarle Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. AurobindoPharma
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Dr. Reddy’s Laboratories Ltd.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. AbbVieInc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Teva Pharmaceutical Industries Ltd
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Mylan N.V.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CiplaInc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. BoehringerIngelheim International GmbH
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Merck & Co., Inc
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Sun Pharmaceutical Industries Ltd
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Bristol-Myers Squibb Company
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy this Research Report study@ https://www.precedenceresearch.com/checkout/1035
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
